This is a citizen science site -- you can contribute by investing and sharing your time.
Common knowledge amoung some professionals (MD and ND):
Vitamin D: Adequate levels of vitamin D might be beneficial for overall health, but its role in preventing or treating lung cancer is not definitive. Some studies have suggested that sufficient vitamin D levels might be associated with better outcomes in cancer patients, although further research is needed.
Omega-3 Fatty Acids: Omega-3 fatty acids found in fish oil have anti-inflammatory properties and might help alleviate certain treatment-related side effects, but their role in lung cancer prevention or treatment is not confirmed.
Probiotics: Probiotics are beneficial for gut health, immune function, and overall well-being. While a healthy gut microbiome is essential, there's no conclusive evidence suggesting that probiotics directly prevent or treat lung cancer.
Antioxidants: Some people consider antioxidants like vitamins C and E, as well as selenium, for their potential to counteract oxidative stress. However, evidence regarding their effectiveness in preventing or treating lung cancer is mixed, and high doses might interfere with cancer treatments.
The Studies below identify bacteria. Check if it has already been reviewed.
| 1 | 📚 |
Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients.
Cancers (Cancers (Basel) ) Vol: 14 Issue: 24 Pages: Pub: 2022 Dec 19 ePub: 2022 Dec 19 Authors Grenda A,Iwan E,Krawczyk P,Frak M,Chmielewska I,Bomba A,Giza A,Rolska-Kopinska A,Szczyrek M,Kieszko R,Kucharczyk T,Jarosz B,Wasyl D,Milanowski J |
| 2 | 📚 |
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis.
Cancers (Cancers (Basel) ) Vol: 14 Issue: 21 Pages: Pub: 2022 Nov 2 ePub: 2022 Nov 2 Authors Hakozaki T,Nolin-Lapalme A,Kogawa M,Okuma Y,Nakamura S,Moreau-Amaru D,Tamura T,Hosomi Y,Takeyama H,Richard C,Hosokawa M,Routy B |
| 3 | 📚 |
Causal influence of gut microbiota on small cell lung cancer: a Mendelian randomization study.
The clinical respiratory journal (Clin Respir J ) Vol: 18 Issue: 5 Pages: e13764 Pub: 2024 May ePub: Authors Yang W,Fan X,Li W,Chen Y |
| 4 | 📚 |
Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit.
Scientific reports (Sci Rep ) Vol: 13 Issue: 1 Pages: 2007 Pub: 2023 Feb 3 ePub: 2023 Feb 3 Authors Haberman Y,Kamer I,Amir A,Goldenberg S,Efroni G,Daniel-Meshulam I,Lobachov A,Daher S,Hadar R,Gantz-Sorotsky H,Urban D,Braun T,Bar J |
| 5 | 📚 |
Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer.
International journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys ) Vol: 115 Issue: 2 Pages: 407-418 Pub: 2023 Feb 1 ePub: 2022 Jul 26 Authors Qiu B,Xi Y,Liu F,Li Y,Xie X,Guo J,Guo S,Wu Y,Wu L,Liang T,Ding Y,Zhang J,Wu Q,Liu H |
| 6 | 📚 |
Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer.
Frontiers in molecular biosciences (Front Mol Biosci ) Vol: 9 Issue: Pages: 1040424 Pub: 2022 ePub: 2022 Oct 24 Authors Shoji F,Yamaguchi M,Okamoto M,Takamori S,Yamazaki K,Okamoto T,Maehara Y |
| 7 | 📚 |
Impact of Gut Dysbiosis on the Risk of Non-Small-Cell Lung Cancer.
International journal of environmental research and public health (Int J Environ Res Public Health ) Vol: 19 Issue: 23 Pages: Pub: 2022 Nov 30 ePub: 2022 Nov 30 Authors Wei YF,Huang MS,Huang CH,Yeh YT,Hung CH |
The Studies below identify substances that has been tried with positive changes (for at least some symptoms in the study). Check if it has already been reviewed.
| 8 | 📚 |
A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis.
Archivos de bronconeumologia (Arch Bronconeumol ) Vol: Issue: Pages: Pub: 2024 May 6 ePub: 2024 May 6 Authors Ashique S,Mishra N,Garg A,Kumar N,Khan Z,Mohanto S,Chellappan DK,Farid A,Taghizadeh-Hesary F |
| 9 | 📚 |
Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis.
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 13 Issue: Pages: 1261284 Pub: 2023 ePub: 2023 Oct 16 Authors Zhang Y,Chen X,Wang Y,Li L,Ju Q,Zhang Y,Xi H,Wang F,Qiu D,Liu X,Chang N,Zhang W,Zhang C,Wang K,Li L,Zhang J |
| 10 | 📚 |
Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer.
Cancer immunology research (Cancer Immunol Res ) Vol: 8 Issue: 10 Pages: 1236-1242 Pub: 2020 Oct ePub: 2020 Jul 14 Authors Tomita Y,Ikeda T,Sakata S,Saruwatari K,Sato R,Iyama S,Jodai T,Akaike K,Ishizuka S,Saeki S,Sakagami T |
| 11 | 📚 |
Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors.
Oncoimmunology (Oncoimmunology ) Vol: 11 Issue: 1 Pages: 2081010 Pub: 2022 ePub: 2022 May 27 Authors Tomita Y,Goto Y,Sakata S,Imamura K,Minemura A,Oka K,Hayashi A,Jodai T,Akaike K,Anai M,Hamada S,Iyama S,Saruwatari K,Saeki S,Takahashi M,Ikeda T,Sakagami T |
| 12 | 📚 |
Live or Heat-Killed Lactobacillus rhamnosus Aerosolization Decreases Adenomatous Lung Cancer Development in a Mouse Carcinogen-Induced Tumor Model.
International journal of molecular sciences (Int J Mol Sci ) Vol: 23 Issue: 21 Pages: Pub: 2022 Oct 22 ePub: 2022 Oct 22 Authors Le Noci V,Bernardo G,Manenti G,Infante G,Khaleghi Hashemian D,Minoli L,Canesi S,Bianchi F,Triulzi T,Arioli S,De Cecco L,Guglielmetti S,Ambrogi F,Recordati C,Gagliano N,Tagliabue E,Sommariva M,Sfondrini L |
The following items have been cited in the above studies
| ID | Studies | Name | AKA |
|---|---|---|---|
| 1777 | 2 | Clostridium butyricum MIYAIRI 588 {Miyarisan} | Miya,Miya-Pro, Cdactin-O |
| 297 | 2 | Escherichia coli Nissle 1917 {Mutaflor} | In use since 1917 |
| 247 | 1 | lactobacillus rhamnosus gg | l rhamnosus gg (probiotics) |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
